This is not good.
"Changes to the primary end point during or after recruitment were omnipresent in randomized clinical trials with immune checkpoint inhibitors for patients with UC, RCC, and NSCLC. Most common were switching to or adding OS as an outcome measure and subpopulations based on PD-L1 expression. Ultimately, published data often do not allow readers to infer what the results would have been if the primary outcome had not been changed."
#Immunology #Immunotherapy #immunooncology #checkpointinhibitors
#Immunooncology #checkpointinhibitors #immunology #immunotherapy
Rare #cancer treated with #Immunotherapy : new data for #sarcoma subtype angiosarcoma, treated with double #checkpointinhibitors and showing clinical effects. But we still need better #biomarkers for #precisionmedicine in #immunology ... @chfloudas @cyrilpedia
https://jitc.bmj.com/content/9/8/e002990
#cancer #Immunotherapy #sarcoma #checkpointinhibitors #biomarkers #precisionmedicine #immunology
'Our studies demonstrate that in vivo trans PD-L1/CD80 interactions do exist between T and tumor cells, and in vivo blockade of trans PD-L1/CD80 interactions or general PD-L1/CD80 interactions augment tumor immunity via expansion of IFN-γ-producing CD8+T cells and NOS2+macrophages in the tumor tissues.'
#immunology #immunooncology #immunotherapy #checkpointinhibitors
#immunology #Immunooncology #immunotherapy #checkpointinhibitors
'In this issue of Nature Medicine, Cascone et al.2share the latest results of their phase 2 platform trial, NEOSTAR, which suggest that the addition of CTLA-4 blockade to neoadjuvant anti-PD-1 plus chemotherapy may augment anti-tumor responses.'
#LungCancer #Immunology #TumorImmunology #immunotherapy #checkpointinhibitors
#immunology #TumorImmunology #immunotherapy #checkpointinhibitors #lungcancer
"As expected, early on-target recognition of melanoma antigens by tumor-specific CD4+ T cells was required. Surprisingly, complete tumor eradication was dependent on neutrophils and partly dependent on inducible nitric oxide synthase."
#Immunology #Immunotherapy #checkpointinhibitors #Neutrophil
#immunology #neutrophil #immunotherapy #checkpointinhibitors
"Over and over, trials evaluating PD-1/PD-L1 inhibitors in advanced prostate cancer have missed the mark. The failures have led to questions as to why—and have prompted oncologists to conclude that new treatment strategies are needed."
#Immunology #immunotherapy #checkpointinhibitors #prostatecancer
#prostatecancer #immunology #immunotherapy #checkpointinhibitors
'We generated personalized libraries of neoantigen–HLA capture reagents to single-cell isolate the T cells and clone their T cell receptors (neoTCRs). Multiple T cells with different neoTCR sequences (T cell clonotypes) recognized a limited number of mutations in samples from seven patients with long-lasting clinical responses.'
#immunotherapy #checkpointinhibitors #immunology
ICYMI, it was a pleasure to interview Nobel-prize winning immunologist Tasuku Honjo about the story behind his lab's discovery of PD1, a classic @embojournal paper from 1992.
🎧 #EMBOPodcast #EMBOJournal #Immunology #immunotherapy #checkpointinhibitors #HistoryOfScience
https://www.embo.org/podcasts/from-cell-death-to-cancer-immunotherapy/
#EMBOPodcast #EMBOJournal #immunology #immunotherapy #checkpointinhibitors #historyofscience
"Here, we show that cGAMP delivery by intratumoral injection of virus-like particles (cGAMP-VLP) led to differentiation of circulating tumor-specific T cells, decreased tumor regulatory T cells (Tregs), and antitumoral responses that synergized with PD1 blockade."
#STING #Immunology #Immunotherapy #checkpointinhibitors
https://www.science.org/doi/10.1126/sciimmunol.abn6612#.Y8G4gZis1IU.twitter
#sting #immunology #immunotherapy #checkpointinhibitors
'We identified three distinct types of ICI-myositis based on transcriptomic analyses. The IL6 pathway was overexpressed in all groups, the type I interferon pathway activation was specific for ICI-DM, the type 2 IFN pathway was overexpressed in both ICI-DM and ICI-MYO1, and only ICI-MYO1 patients developed myocarditis.'
#Preprint #immunotherapy #checkpointinhibitors
https://www.biorxiv.org/content/10.1101/2022.12.12.520136v1?med=mas
#preprint #immunotherapy #checkpointinhibitors
#safety #celltherapy #celltherapies #immunotherapy #genetherapy #cellulartherapeutics #IO #cancer #oncology #dlbcl #lymphoma #cartecells #cartcellrx #nkcells #nkcars #bispecifics #tcellengagers #bloodcancers #lymphoma #multiplemyeloma #solidtumors #Breastcancer #GIcancer #cartcell #cartcells #cartcellrx #msc #mesenchymalstemcells #mesenchymalstemcell #CRISPR #crisprcas9 #genetherapy #geneediting #checkpointinhibitors #bmt #bmtrx #bmtsm #tcellrx
#safety #CellTherapy #celltherapies #Immunotherapy #genetherapy #cellulartherapeutics #IO #cancer #oncology #dlbcl #lymphoma #cartecells #cartcellrx #NKcells #nkcars #bispecifics #tcellengagers #BloodCancers #MultipleMyeloma #solidtumors #breastcancer #gicancer #CARTCell #CARTCells #msc #mesenchymalstemcells #mesenchymalstemcell #crispr #crisprcas9 #geneediting #checkpointinhibitors #BMT #bmtrx #bmtsm #tcellrx
#Immunology #Immunotherapy
#checkpointinhibitors
"In this Review we mark the tenth anniversary of the approval of ipilimumab and discuss the foundational scientific history of ICB, together with the history of the discovery, development and elucidation of the mechanism of action of the first generation of drugs targeting the #CTLA4 and #PD1 pathways."
#immunology #immunotherapy #checkpointinhibitors #CTLA4 #pd1
#cancer #oncology #cartcell #cartcellrx #immunotherapy #genetherapy #celltherapy #immunology #cancercare #preventativemedicine #cellulartherapeutics #celltherapies #checkpointinhibitors #patientcare #patientcenteredcare #patients #support #patientsupport #advocacy #coronavirus #COVID19 #pandemic #COVID #sars_cov_2 #covid19research #pandemic2020 #SARSCoV2 #coronavirus #Corona #pandemia #cancer #oncology
#cancer #oncology #CARTCell #cartcellrx #Immunotherapy #genetherapy #CellTherapy #immunology #cancercare #preventativemedicine #cellulartherapeutics #celltherapies #checkpointinhibitors #patientcare #patientcenteredcare #patients #support #patientsupport #advocacy #coronavirus #COVID19 #pandemic #COVID #SARS_COV_2 #covid19research #pandemic2020 #SarsCoV2 #corona #pandemia